ArticleFrontiers in surgery2026
Combined immunohistochemistry and FISH testing for diagnosing metaplastic thymoma: a case report of misdiagnosis as pulmonary mucinous epidermoid carcinoma.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Simple summary: Differentiating metaplastic thymoma from pulmonary mucoepidermoid carcinoma through immunohistochemistry and FISH testing provides diagnostic evidence for clinical practice. This study investigates the clinical-pathological features, immunophenotype, and di agnostic criteria of metaplastic thymoma (MT), distinguishing it from pulmonary mucinous epidermoid carcinoma (PEMC). Methods: Clinical data from a single patient with surgically confirmed metaplastic thymoma were collected. Histological examination, immunohistochemical staining, and molecular testing were performed. Results: The patient was a middle-aged woman. Postoperative pathological immunohistochemistry revealed a tumor composed of relatively benign epithelioid and spindle cells. Epithelioid cells exhibited nests with mildly enlarged nuclei and rare mitotic figures, accompanied by focal degenerative necrosis. Immunohistochemistry results: CD117 (-), CD20 (-), CD3 (speckled +), CD34 (-), CD5 (speckled +), CD99 (-), CK20 (-), CK7 (partial +), EMA (spindle cells +; epithelioid cells speckled perinuclearly +), Ki67 (5%+), P53 (80%+), P63 (+), Syn (-), TDT (-). Molecular testing: YAP1-MAML2 gene break-up rearrangement detected. Conclusion: Metaplastic thymoma represents a rare subtype of thymoma. Diagnosis requires integration of clinical presentation, microscopic morphology, immunohistochemical features, and molecular biology data to enhance diagnostic accuracy and facilitate effective differentiation from pulmonary mucinous epidermoid carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.